BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6725 related articles for article (PubMed ID: 2430706)

  • 1. Circulating melanoma-associated antigen detected by monoclonal antibody NKI/C-3.
    Vennegoor C; Rümke P
    Cancer Immunol Immunother; 1986; 23(2):93-100. PubMed ID: 2430706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/C-3.
    Vennegoor C; Calafat J; Hageman P; van Buitenen F; Janssen H; Kolk A; Rümke P
    Int J Cancer; 1985 Mar; 35(3):287-95. PubMed ID: 3882581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ME491 melanoma-associated glycoprotein family: antigenic identity of ME491, NKI/C-3, neuroglandular antigen (NGA), and CD63 proteins.
    Demetrick DJ; Herlyn D; Tretiak M; Creasey D; Clevers H; Donoso LA; Vennegoor CJ; Dixon WT; Jerry LM
    J Natl Cancer Inst; 1992 Mar; 84(6):422-9. PubMed ID: 1371549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody specific for cells of the melanocyte lineage.
    Vennegoor C; Hageman P; Van Nouhuijs H; Ruiter DJ; Calafat J; Ringens PJ; Rümke P
    Am J Pathol; 1988 Jan; 130(1):179-92. PubMed ID: 3276209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoassay for melanoma-associated proteoglycan in the sera of patients using monoclonal and polyclonal antibodies.
    Ross AH; Herlyn M; Ernst CS; Guerry D; Bennicelli J; Ghrist BF; Atkinson B; Koprowski H
    Cancer Res; 1984 Oct; 44(10):4642-7. PubMed ID: 6380710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel neuroglandular antigen (NGA) expressed on abnormal human melanocytes.
    Sikora LK; Pinto A; Demetrick DJ; Dixon WT; Urbanski SJ; Temple W; Jerry LM
    Int J Cancer; 1987 Feb; 39(2):138-45. PubMed ID: 3804488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mouse monoclonal antibodies recognizing melanoma-associated ganglioside antigens].
    Hirabayashi Y; Matsumoto M; Taniguchi M
    Seikagaku; 1985 Oct; 57(10):1385-90. PubMed ID: 2418135
    [No Abstract]   [Full Text] [Related]  

  • 8. Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens.
    Harper JR; Bumol TF; Reisfeld RA
    Hybridoma; 1982; 1(4):423-32. PubMed ID: 6208137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Workshop on monoclonal antibodies to human melanoma-associated antigens: findings of the Seattle group.
    Hellström I; Brown JP; Hellström KE
    Hybridoma; 1982; 1(4):399-402. PubMed ID: 6208136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of a tumor-associated glycoprotein antigen in serum and urine of melanoma patients by murine monoclonal antibody (AD1-40F4) in enzyme immunoassay.
    Euhus DM; Gupta RK; Morton DL
    J Clin Lab Anal; 1989; 3(3):184-90. PubMed ID: 2754533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant.
    Kimmel KA; Carey TE; Judd WJ; McClatchey KD
    J Natl Cancer Inst; 1986 Jan; 76(1):9-19. PubMed ID: 2416979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse monoclonal antibody (FKH1) detecting human melanoma-associated antigens.
    Fukaya T; Hashimoto K; Eto H; Mehregan A
    Cancer Res; 1986 Oct; 46(10):5195-200. PubMed ID: 3756874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of systemic interferon-alpha (IFN-alpha) on the antigenic phenotype of melanoma metastases. EORTC melanoma group cooperative study No. 18852.
    von Stamm U; Bröcker EB; von Depka Prondzinski M; Ruiter DJ; Rümke P; Broding C; Carrel S; Lejeune FJ
    Melanoma Res; 1993 Jun; 3(3):173-80. PubMed ID: 8104570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double determinant immunoassay with monoclonal antibodies against human blood group determinants.
    Herlyn M; Shen JW; Sears HF; Civin CI; Verrill HL; Goldberg EM; Koprowski H
    Clin Exp Immunol; 1984 Jan; 55(1):23-35. PubMed ID: 6198117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants.
    Giacomini P; Natali P; Ferrone S
    J Immunol; 1985 Jul; 135(1):696-702. PubMed ID: 2582052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical and biosynthetic analysis of monoclonal antibody-defined melanoma-associated antigen.
    Bumol TF; Chee DO; Reisfeld RA
    Hybridoma; 1982; 1(3):283-92. PubMed ID: 6208129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic uveal melanoma: an ocular melanoma associated antigen in the serum of patients with metastatic disease.
    Donoso LA; Felberg NT; Edelberg K; Borlinghaus P; Herlyn M
    J Immunoassay; 1986; 7(4):273-83. PubMed ID: 3805289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antiidiotypic antibodies related to the p97 human melanoma antigen.
    Kahn M; Hellström I; Estin CD; Hellström KE
    Cancer Res; 1989 Jun; 49(12):3157-62. PubMed ID: 2470502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution.
    Hofbauer GF; Kamarashev J; Geertsen R; Böni R; Dummer R
    Melanoma Res; 1998 Aug; 8(4):337-43. PubMed ID: 9764809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of a mouse monoclonal antibody, MoAb HMSA-1, against a melanosomal fraction of human malignant melanoma.
    Akutsu Y; Jimbow K
    Cancer Res; 1986 Jun; 46(6):2904-11. PubMed ID: 3516387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 337.